NCT01374776已完成4 期
Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance In Non Anemic Premenopausal Women With Low Ferritin Levels
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- Mitochondrial capacity (Phosphocreatine Recovery rate assessed by 31P-MR-spectroscopy of the lower leg muscle)
研究概览
简要总结
Effect of intravenous iron substitution (iron carboxymaltose (Ferinject®), total dose 15 mg/ kg (maximal dose: 1000mg) in 250 ml 0.9 % NaCl; intravenous infusion in 20 min)in non-anemic premenopausal women with iron deficiency on
Primary objective:
- Mitochondrial capacity (Phosphocreatine Recovery rate assessed by 31P-MR-spectroscopy of the lower leg muscle)
Secondary objectives:
- Maximal oxygen uptake during a graded cycling exercise test and time to exhaustion at submaximal power during a constant-load cycling exercise test
- Plantarflexor muscle fatiguability as assessed by isokinetic dynamometry
- Trial with medicinal product
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
intravenous iron carboxymaltose
Experimental
intravenous iron carboxymaltose infusion
干预措施: intravenous iron carboxymaltose (Drug)
结局指标
主要结局
Mitochondrial capacity (Phosphocreatine Recovery rate assessed by 31P-MR-spectroscopy of the lower leg muscle)
时间窗: one year
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
终止
4 期
Impact of intravenous iron injections on musculoskeletal function in older adultsISRCTN13325706iverpool Hope University100
尚未招募
2 期
Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal CancerIron-deficiencyColorectal CancerNCT05220800Zealand University Hospital134
已完成
不适用
Effect of intravenous iron in alleviating symptoms of exhaustion in non-anaemic pre-menopausal womeReduced physical and mental performance in pre-menopausal womenNutritional, Metabolic, EndocrineISRCTN78430425Vifor Pharma, Vifor (International) Ltd (Switzerland)100
招募中
不适用
Comparison between intravenous iron therapy and autologous blood transfusion on postoperative anemia in patients undergoing two-jaws orthognathic surgeryKCT0003680The Catholic University of Korea, Seoul St. Mary's Hospital66
撤回
4 期
Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection FractionHeart Failure With Normal Ejection FractionIron-deficiencyNCT05477498Cantonal Hosptal, Baselland